Chloroptic
FDA Approves Dotarem, a New MRI Agent »
"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Chloroptic
(Generic versions may still be available.)
Chloroptic®
(chloramphenicol) Ophthalmic Solution, USP 0.5% sterile
Bone marrow hypoplasia including aplastic anemia and death has been reported following topical application of chloramphenicol. Chloramphenicol should not be used when less potentially dangerous agents would be expected to provide effective treatment.
DRUG DESCRIPTION
Chloroptic® (chloramphenicol ophthalmic solution, USP) is a topical anti-infective product for ophthalmic use.
Structural Formula

C11H12Cl12N205
Mol Wt 323.13
Chemical Name:
D-threo-(-)-2,2-Dichloro-N-143-hydroxy-a-(hydroxymethyl)..
p-nitrophenethyl] acetamide
Contains:
| Active: chloramphenicol | 0.5% (5mg/ml) |
| Preservative: chlorobutanol (chloral deny.) | 0.5%; |
Inactives: polyethylene glycol 300; polyoxyl 40 stearate; sodium hydroxide or hydrochloric acid to adjust PH; and purified water.
Last reviewed on RxList: 1/2/2005
This monograph has been modified to include the generic and brand name in many instances.
Additional Chloroptic Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.






